Maurizio A Brausi

Summary

Affiliation: Institute of Infectious Diseases and Public Health
Country: Italy

Publications

  1. ncbi The motion: Radical cystectomy in the elderly is becoming a standard treatment for bladder cancer
    Maurizio A Brausi
    Department of Urology, AUSL Modena, Modena, Italy
    Eur Urol 51:1435-6. 2007
  2. ncbi The use of local anesthesia with N-DO injector (Physion) for transurethral resection (TUR) of bladder tumors and bladder mapping: preliminary results and cost-effectiveness analysis
    Maurizio A Brausi
    Department of Urology, AUSL Modena, Modena, Italy
    Eur Urol 52:1407-11. 2007
  3. doi A review of current guidelines and best practice recommendations for the management of nonmuscle invasive bladder cancer by the International Bladder Cancer Group
    Maurizio Brausi
    Department of Urology, AUSL Modena, Modena, Italy
    J Urol 186:2158-67. 2011
  4. ncbi Immediate radical prostatectomy in patients with atypical small acinar proliferation. Over treatment?
    Maurizio Brausi
    Department of Urology, Ospedale Sant Agostino Estense, University of Modena and Reggio Emilia, Via Sant Agostino 18, 41100 Modena, Italy
    J Urol 172:906-8; discussion 908-9. 2004
  5. ncbi Retroperitoneal lymph node dissection (RPLD) in conjunction with nephroureterectomy in the treatment of infiltrative transitional cell carcinoma (TCC) of the upper urinary tract: impact on survival
    Maurizio A Brausi
    Department of Urology, AUSL Modena, Carpi Modena, Italy
    Eur Urol 52:1414-8. 2007
  6. ncbi New strategies in the treatment of Ta-T1 transitional cell carcinoma (TCC) of the bladder
    Maurizio A Brausi
    AUSL Modena, Italy
    ScientificWorldJournal 6:2632-7. 2006
  7. doi Can gemcitabine instillation ablate solitary low-risk non-muscle-invasive bladder cancer? Results of a phase II marker lesion study
    Maurizio A Brausi
    Department of Urology, Local Health Unit, Modena, Italy
    Urol Int 87:470-4. 2011

Detail Information

Publications7

  1. ncbi The motion: Radical cystectomy in the elderly is becoming a standard treatment for bladder cancer
    Maurizio A Brausi
    Department of Urology, AUSL Modena, Modena, Italy
    Eur Urol 51:1435-6. 2007
  2. ncbi The use of local anesthesia with N-DO injector (Physion) for transurethral resection (TUR) of bladder tumors and bladder mapping: preliminary results and cost-effectiveness analysis
    Maurizio A Brausi
    Department of Urology, AUSL Modena, Modena, Italy
    Eur Urol 52:1407-11. 2007
    ....
  3. doi A review of current guidelines and best practice recommendations for the management of nonmuscle invasive bladder cancer by the International Bladder Cancer Group
    Maurizio Brausi
    Department of Urology, AUSL Modena, Modena, Italy
    J Urol 186:2158-67. 2011
    ....
  4. ncbi Immediate radical prostatectomy in patients with atypical small acinar proliferation. Over treatment?
    Maurizio Brausi
    Department of Urology, Ospedale Sant Agostino Estense, University of Modena and Reggio Emilia, Via Sant Agostino 18, 41100 Modena, Italy
    J Urol 172:906-8; discussion 908-9. 2004
    ..We determined the incidence of ASAP at our institution and evaluated the role of immediate radical prostatectomy (RP) in these patients...
  5. ncbi Retroperitoneal lymph node dissection (RPLD) in conjunction with nephroureterectomy in the treatment of infiltrative transitional cell carcinoma (TCC) of the upper urinary tract: impact on survival
    Maurizio A Brausi
    Department of Urology, AUSL Modena, Carpi Modena, Italy
    Eur Urol 52:1414-8. 2007
    ....
  6. ncbi New strategies in the treatment of Ta-T1 transitional cell carcinoma (TCC) of the bladder
    Maurizio A Brausi
    AUSL Modena, Italy
    ScientificWorldJournal 6:2632-7. 2006
    ..Also in the pipeline are new approaches to treatment such as gene therapy, but these will need to be developed much more before they become part of routine practice...
  7. doi Can gemcitabine instillation ablate solitary low-risk non-muscle-invasive bladder cancer? Results of a phase II marker lesion study
    Maurizio A Brausi
    Department of Urology, Local Health Unit, Modena, Italy
    Urol Int 87:470-4. 2011
    ..The purpose of this phase II study was to evaluate whether low-risk non-muscle-invasive bladder cancer can be ablated with intravesical gemcitabine in a marker lesion study...